PAX5 and Osteopenia: In non-dialysis CKD patients, BSAP has been identified as an independent predictor of total hip BMD; furthermore, monitoring the B/I isoform of BSAP predicts osteopenia in the hip and the distal third of the radius in stage 3 CKD [136].